Talk:Locus Biosciences

CRISPR CAS3 section
I'm thinking that it would be for the best to drop this section. A better treatment would be to present what, if any, enhancements on the technology the company has made. A brief statement related to why the company chose CAS3 vs. CAS9 would be sufficient. This would be a significant change to the article, so I'll not unilaterally make it at this time. --User:Ceyockey ( talk to me ) 01:31, 20 August 2022 (UTC)